We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
JAMA Patient Page |

Screening for Cervical Cancer FREE

Jill Jin, MD, MPH
JAMA. 2014;312(21):2302. doi:10.1001/jama.2014.16296.
Text Size: A A A
Published online

Screening for cervical cancer is done by Pap smears and HPV testing.


The cervix is the bottom part of the uterus (the womb). Often, cervical cancer in its early stages causes no symptoms. Therefore, the best way to find early cervical cancer is to test all women in a certain age group, even if they have no symptoms. This is known as cervical cancer screening. Screening tests for cervical cancer can find not only early cancers but also abnormal, precancerous cells that have a high chance of turning into cancer. Cervical cancer or precancer treated at an early stage can usually be cured.


There are 2 tests that can be used for cervical cancer screening: a Papanicolaou (Pap) smear and a human papillomavirus (HPV) test. One or both of these tests is recommended depending on a woman’s age and medical history.

A Pap smear is done by using a speculum (a device that looks like a duck beak) to keep the walls of the vagina open, and using a small brush or spatula to collect some cells from the cervix. This is a quick procedure done in a doctor’s office. The cervical cells are then looked at under a microscope to identify cancer or precancerous cells.

An HPV test is also done using a sample of cells from the cervix. These cells can be analyzed to look for the HPV virus, which can infect cervical cells and cause cervical cancer in some women.


In 2012, the US Preventive Services Task Force and the American College of Obstetricians and Gynecologists (ACOG) released updated recommendations on who should be tested for cervical cancer and what types of tests should be done. These recommendations replaced older ones that stated that women should be tested every year—this is no longer the case.

In the December 3, 2014, issue of JAMA, a JAMA Clinical Guidelines Synopsis article discusses the ACOG guideline on cervical cancer screening. A summary of the recommendations is below.


  • All women should have their first Pap smear at age 21 years. Screening before age 21 years is not recommended, even for women younger than 21 who are sexually active.

  • If the results are normal, Pap smears should be done every 3 years until age 30 years.

  • After age 30 years, women can continue to have Pap smears every 3 years or they can have a Pap smear with HPV testing every 5 years.

  • Women can stop having Pap smears at age 65 years if they have had routine screenings with normal results for the prior 10 years.

Women who have abnormal Pap smear results may need either further testing (such as a biopsy of the cervix) or a follow-up Pap smear sooner than 3 years.


  • Testing for HPV is not recommended for women younger than 30 years.

  • After age 30 years, women can have an HPV test along with a Pap smear every 5 years.

  • Women can stop having HPV tests at age 65 years if they have had routine screening with normal results for the prior 10 years.

These recommendations are the same for women who have and who have not received the HPV vaccine.

Box Section Ref ID

For More Information


The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.

Source: Volerman A, Cifu AS. Cervical cancer screening. JAMA. doi: 10.1001/jama.2014.14992.

Topic: Preventive Medicine



Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Spanish Patient Page: Prueba de detección de cáncer de cuello uterino

Supplemental Content

Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles